143 Results for “William Lazonick”
-
Article
China’s Development Path: Indigenous Innovation and Global Competition
Aug 22, 2022
China’s successful technological development path stands in contrast to the corporate financialization model in the United States
-
Working Paper
Working Paper SeriesChina’s Development Path: Government, Business, and Globalization in an Innovating Economy
Aug 2022
China’s successful technological development path stands in contrast to the corporate financialization model in the United States
-
Article
Letter to SEC: How Stock Buybacks Undermine Investment in Innovation for the Sake of Stock-Price Manipulation
Apr 1, 2022
A comment on the Securities and Exchange Commission’s proposed rule “Share Repurchase Disclosure Modernization”
-
Working Paper
Working PaperInvesting in Innovation: A Policy Framework for Attaining Sustainable Prosperity in the United States
Apr 2022
Business firms are not alone in making investments in the productive capabilities required to generate innovative goods and services. Household units and government agencies also make investments in productive capabilities upon which business firms rely for their own investment activities.
-
Article
Where Did You Go, Vice President Joe?
Mar 4, 2022
President Biden’s first SOTU Address was a missed opportunity to say what he knows to be true: Stock buybacks manipulate the market and leave most Americans worse off
-
Working Paper
Working paperEquality Denied: Tech and African Americans
Feb 2022
EEO-1 employment data document the vast over-representation of Asian Americans and vast under-representation of African Americans at tech companies in recent years. How did this happen?
-
Article
African Americans in Tech: What the EEO-1 Numbers Reveal
Feb 22, 2022
EEO-1 employment data document the vast over-representation of Asian Americans and vast under-representation of African Americans at tech companies in recent years. How did this happen?
-
News
William Lazonick's INET-Funded Research Is Cited in Quartz
Feb 17, 2022
“What is the motivation for tax avoidance? To maximize profits and juice the stock price, of course. A research team led by William Lazonick at the University of Massachusetts reports in Harvard Business Review that from 2009 to 2019, S&P 500 companies spent over 90% of net income on buybacks and dividends, with the highest levels achieved after the 2017 tax cuts, in 2018 and 2019. Taking on corporate debt to finance share repurchases has become commonplace. Never mind that share buybacks deplete corporate treasuries of cash to weather setbacks and to fund productive investment in labor and R&D.”
-
Article
Beyond Price Caps: A Regulatory Framework for Pricing of Medicine Innovation
Feb 3, 2022
US regulators can step in to ensure drug pricing both supports patient access and drug development
-
Working Paper
Working Paper SeriesPricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access
Feb 2022
US regulators can step in to ensure drug pricing both supports patient access and drug development
-
News
OSF and INET Complete 12 Year Collaboration on New Economic Thinking
Jan 5, 2022
The Institute for New Economic Thinking (INET) and the Open Society Foundations (OSF) announced that OSF has made a gift of $23.5 million to INET. The grant marks the completion of the organizations’ 12-year collaboration.
-
News
William Lazonick’s INET funded research is cited in the American Prospect.
Oct 26, 2021
“Nobody but those top corporate executives was really paying attention to share buybacks until the middle of the last decade, when University of Massachusetts economist William Lazonick wrote an article for the Harvard Business Review documenting the surprising and depressing fact that the companies that had belonged to the Fortune 500 during the previous decade had spent so much on share buybacks and dividends that the total was either equal to or actually exceeded their profits.”
-
Article
Welcome to the Emergency Room. A Wall Street Honcho Will Decide Your Treatment.
Oct 12, 2021
Doctors and medical experts say private equity firms and profiteering corporations are putting American lives at risk and compromising the practice of medicine.
-
Working Paper
Working Paper SeriesWhy the CHIPS Are Down: Stock Buybacks and Subsidies in the U.S. Semiconductor Industry
Oct 2021
To strengthen the American semiconductor industry, Congress should condition additional funds on suspending stock buybacks
-
Article
Does America Want a CHIPS for Buybacks Act?
Oct 4, 2021
To strengthen the American semiconductor industry, Congress should condition additional funds on suspending stock buybacks